Abbonarsi

The traditional Chinese medicine formula Fufang-Zhenzhu-Tiaozhi protects myocardia from injury in diabetic minipigs with coronary heart disease - 19/03/21

Doi : 10.1016/j.biopha.2021.111343 
Lixia Song a, d, 1, Dongxing Zhang a, d, 1, Caijuan Guo a, d, 1, Zhanhui Gu a, d, 1, Lexun Wang a, b, c, d, 1, Yu Si Yao e, Hong Wang a, d, Zhihuan Zeng a, d, Weixuan Wang a, b, c, d, Yiqi Yang a, b, c, d, Weijian Bei a, b, c, d, 1, Xianglu Rong a, b, c, d, 1, Jiao Guo a, b, c, d,
a Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, China 
b Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, China 
c Key Unit of Modulating Liver to Treat Hyperlipemia SATCM (State Administration of Traditional Chinese Medicine), China 
d Institute of Chinese Medicinal Sciences, Guangdong Pharmaceutical University, Guangdong TCM Key Laboratory against Metabolic Diseases, China 
e Department of Cardiovascular Diseases, the First Affiliated Hospital of Guangdong Pharmaceutical University, China 

Correspondence to: Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, The Institute of Chinese Medicinal Sciences, Guangdong Pharmaceutical University, Guangzhou 510006, China.Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, The Institute of Chinese Medicinal Sciences, Guangdong Pharmaceutical UniversityGuangzhou510006China

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

pagine 10
Iconografia 7
Video 0
Altro 0

Abstract

Background and purpose

Diabetes mellitus (DM) is a major risk factor for coronary heart disease (CHD). Previous research has reported that the Fufang-Zhenzhu-Tiaozhi (FTZ) formula has obvious effects on the treatment of dyslipidemia and hyperglycemia. In the present study, we intended to establish a convenient DM-CHD model in minipigs and investigated the protective effect of FTZ against myocardial injury and its mechanism.

Methods

The DM-CHD model was established by a high-fat/high-sucrose/high-cholesterol diet (HFSCD) combined with balloon injury in the coronary artery. Subsequently, sixteen Wuzhishan minipigs were assigned to three groups: control group, model group, and FTZ group. The model group and FTZ group were given a HFSCD, while the control group was given a normal diet (ND). FTZ was given with meals in the FTZ group. During this time, biochemical parameters, such as total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein (HDL-C), and fasting blood glucose (FBG), were measured by using testing kits. Insulin (INS) was determined by ELISA, and the homeostasis model assessment index of insulin resistance (HOMA-IR) was calculated to evaluate insulin resistance levels. After FTZ administration, the plasma levels of lactate dehydrogenase (LDH), creatine kinase isoenzyme MB (CK-MB), and cardiac troponin I (cTnI) were measured by using ELISA kits to evaluate myocardial injury. Coronary artery stenosis was analyzed by angiographic and HE staining. Myocardial ischemia was assayed with electrocardiogram (ECG). Moreover, cytokines, including interleukin-6 (IL-6), hypersensitive C-reactive protein (hs-CRP), and tumor necrosis factor-alpha (TNF-α), were measured by ELISA kits to assess inflammation. The myocardial tissue was collected, and the pathological morphology was observed by transmission electron microscopy (TEM), HE staining, and Masson staining. Western blots were used to detect the expression of PI3K, AKT, p-AKT, p-NF-κB, and NF-κB.

Results

A DM-CHD model in minipigs with glucose-lipid metabolism disorder, coronary artery incrassation and myocardial damage was successfully established through balloon injury in the coronary artery combined with HFSCD. FTZ effectively inhibited coronary artery incrassation and protected the myocardium against injury in DM-CHD minipigs. FTZ decreased proinflammatory cytokine levels and upregulated the protein expression of the PI3K/Akt pathway in the myocardium.

Conclusions

A novel DM-CHD model in minipigs was successfully established through balloon injury in the coronary artery combined with HFSCD. FTZ has a protective effect against myocardial injury in DM-CHD by inhibiting inflammation and activating the PI3K/AKT signaling pathway.

Il testo completo di questo articolo è disponibile in PDF.

Graphical Abstract




ga1

Il testo completo di questo articolo è disponibile in PDF.

Highlights

A novel DM-CHD model was successfully established through balloon injury in the coronary artery combined with HFSCD.
FTZ can alleviate the disorder of glucose metabolism in minipigs of DM-CHD.
FTZ effectively inhibited the coronary artery incrassation and protected myocardium against injured in minipigs of DM-CHD.
FTZ alleviates inflammation cytokine levels and up-regulated the protein expression of the PI3K/Akt pathway in myocardium.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Fufang-Zhenzhu-Tiaozhi (FTZ), Myocardial injury, Diabetes mellitus (DM), Coronary heart disease (CHD), Inflammation


Mappa


© 2021  The Authors. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 137

Articolo 111343- Maggio 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • Inhibitory effects on chondrosarcoma cell metastasis by Senna alata extract
  • Athicha Kittiwattanokhun, Siritron Samosorn, Sukanda Innajak, Ramida Watanapokasin
| Articolo seguente Articolo seguente
  • Chemopreventive effects of Melastoma malabathricum L. extract in mammary tumor model via inhibition of oxidative stress and inflammatory cytokines
  • Vikas Kumar, Richa Sachan, Mahfoozur Rahman, Rehan Abdur Rub, Dinesh Kumar Patel, Kalicharan Sharma, Prashant Gahtori, F.A. Al-abbasi, Sultan Alhayyani, Firoz Anwar, Hyung Sik Kim

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.